Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1993; Volume 43,Issue 5
  • You have access
    Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.
    D Krautwurst, J Hescheler, D Arndts, W Lösel, R Hammer and G Schultz
    Molecular Pharmacology May 1993, 43 (5) 655-659;
  • You have access
    Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate beta-lyase.
    S J Perry, M A Schofield, M MacFarlane, E A Lock, L J King, G G Gibson and P S Goldfarb
    Molecular Pharmacology May 1993, 43 (5) 660-665;
  • You have access
    Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    V A Boundy, R R Luedtke, R P Artymyshyn, T M Filtz and P B Molinoff
    Molecular Pharmacology May 1993, 43 (5) 666-676;
  • You have access
    Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium.
    G Servant, G Boulay, R Bossé, E Escher and G Guillemette
    Molecular Pharmacology May 1993, 43 (5) 677-683;
  • You have access
    delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    P Y Law and H H Loh
    Molecular Pharmacology May 1993, 43 (5) 684-693;
  • You have access
    Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study.
    M C Steel and N J Buckley
    Molecular Pharmacology May 1993, 43 (5) 694-701;
  • You have access
    Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    S T Davis and S H Berger
    Molecular Pharmacology May 1993, 43 (5) 702-708;
  • You have access
    Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
    J L Kirkland, L Murthy and G M Stancel
    Molecular Pharmacology May 1993, 43 (5) 709-714;
  • You have access
    Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    P De Isabella, G Capranico, M Palumbo, C Sissi, A P Krapcho and F Zunino
    Molecular Pharmacology May 1993, 43 (5) 715-721;
  • You have access
    Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat.
    J Kapitulnik and F J Gonzalez
    Molecular Pharmacology May 1993, 43 (5) 722-725;
  • You have access
    Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    R C Ferry, C D Unsworth and P B Molinoff
    Molecular Pharmacology May 1993, 43 (5) 726-733;
  • You have access
    Subsecond modulation of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5'-O-(3-thio)triphosphate in permeabilized neutrophils.
    R R Neubig and L A Sklar
    Molecular Pharmacology May 1993, 43 (5) 734-740;
  • You have access
    Isolation of glucagon antagonists by random molecular mutagenesis and screening.
    R A Smith, R Sisk, P Lockhart, S Mathewes, T Gilbert, K Walker and J Piggot
    Molecular Pharmacology May 1993, 43 (5) 741-748;
  • You have access
    Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    A Malmberg, D M Jackson, A Eriksson and N Mohell
    Molecular Pharmacology May 1993, 43 (5) 749-754;
  • You have access
    A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
    M S Choudhary, S Craigo and B L Roth
    Molecular Pharmacology May 1993, 43 (5) 755-761;
  • You have access
    Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    S Mantey, H Frucht, D H Coy and R T Jensen
    Molecular Pharmacology May 1993, 43 (5) 762-774;
  • You have access
    Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    M Mimeault, A Fournier, J Féthiere and A De Léan
    Molecular Pharmacology May 1993, 43 (5) 775-782;
  • You have access
    Inhalational anesthetic actions on voltage-gated ion currents of bovine adrenal chromaffin cells.
    J J Pancrazio, W K Park and C Lynch
    Molecular Pharmacology May 1993, 43 (5) 783-794;
  • You have access
    Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding.
    R F Squires and E Saederup
    Molecular Pharmacology May 1993, 43 (5) 795-800;
  • You have access
    Comparison of interactions of [3H]muscimol, t-butylbicyclophosphoro[35S]thionate, and [3H]flunitrazepam with cloned gamma-aminobutyric acidA receptors of the alpha 1 beta 2 and alpha 1 beta 2 gamma 2 subtypes.
    J F Pregenzer, W B Im, D B Carter and D R Thomsen
    Molecular Pharmacology May 1993, 43 (5) 801-806;
  • You have access
    Modulation by albumin of neuronal cholinergic sensitivity.
    D Gurantz, J F Margiotta, A T Harootunian and V E Dionne
    Molecular Pharmacology May 1993, 43 (5) 807-812;
  • You have access
    Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.
    M R Bowlby
    Molecular Pharmacology May 1993, 43 (5) 813-819;
  • You have access
    Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.
    S Hering, A Savchenko, C Strübing, M Lakitsch and J Striessnig
    Molecular Pharmacology May 1993, 43 (5) 820-826;
  • You have access
    Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver.
    A Lemoine, J C Gautier, D Azoulay, L Kiffel, C Belloc, F P Guengerich, P Maurel, P Beaune and J P Leroux
    Molecular Pharmacology May 1993, 43 (5) 827-832;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 43, Issue 5
1 May 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics